Peptidyl epoxides as inhibitors of α-chymotrypsin: Remarkable change from irreversible to reversible competitive inhibitor as a consequence of the improvement of binding affinity

Bioorganic and Medicinal Chemistry Letters

Volumn 6, Issue 23, 1996, Pages 2837-2840

  Kim, Dong H ^a   Li, Zhi Hong ^a   Lee, Soo Suk ^a  

^a Pohang University of Science and Technology (POSTECH)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BUTYRIC ACID DERIVATIVE; CHYMOTRYPSIN A; CHYMOTRYPSIN INHIBITOR;

ARTICLE; BINDING AFFINITY; COMPETITIVE INHIBITION; DRUG SYNTHESIS; ENZYME BINDING; ENZYME INHIBITION; STRUCTURE ACTIVITY RELATION;

EID: 0030568132     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(96)00536-7     Document Type: Article

References (22)

1. 1. (a) Blow, D. M. In The Enzymes, 3rd ed., Boyer, P. D., Ed., Academic Press, New York, 1971; chapter 6.
2. (b) Hess, G. P. In The Enzymes, 3rd ed., Boyer, P. D., Ed., Academic Press, New York, 1971; chapter 7.
3. (c) Dixon, M.; Webb, E. C. Enzymes, 3rd ed., Academic Press, New York, 1979; pp 301-307.
4. 2. (a) Janoff, A. Ann. Rev. Respi. Dis. 1985, 132, 417-433.
5. (b) Krantz A, Ann.. Rep. Med Chem. 1933, 28, 187-196.
6. (c) Hiasta, D. J.; Pagani, E. D. Ann. Rep. Med Chem. 1934, 29, 195-204.
7. (d) Henkin, J. Ann.. Rep. Med Chem. 1933, 28, 151-160.
8. (e) Fischer, G. Natural Products Reports 1988, 465-495.
9. (f) Walpole, C. S. J.; Wrigglesworth, R. Natural Products Reports 1988, 311-346.
10. 3. Kim, D. H.; Li, Z.-H. Bioorg. Med Chem. Lett. 1994, 4, 2297-2302.
11. 4. Kim, Y. J.; Li, Z.-H.; Kim, D. H.; Hahn, J. H. Bioorg. Med. Chem. Lett. 1996, 6, 1449-1452.
12. 5. (a) Segal, D. M. Biochemistry 1972, 11, 349-356.
13. (b) Segal, D. M.; Powers, J. C.: Cohen, G. H.; Davies, D. R.; Wilcox, P. E. Biochemistry 1971, 10, 3728-3738,
14. (c) Baumann, W. K.; Bizzoreo, S. A.; Dutler, H.; Eur. J. Biochem. 1973, 39, 381-391.
15. 6. Albeck, A.; Persky, R. J. Org. Chem. 1994, 59, 653-657.
16. 13C NMR δ 25.08, 25.65, 28.54, 39.57, 44.67, 49.07, 50.74, 60.84, 126.30, 126.91, 127.48, 127.73, 130.61, 136.66, 137.99, 171,23, 171.35.
17. 8. Kim, D. H.; Ryoo, J. J. Bioorg. Med Chem. Lett. 1995, 5, 1287-1292.
18. 9. Dixon, M. Biochem. J. 1953, 55, 170-171.
19. 10. Kim, D. H. Bioorg. Med Chem. Lett. 1993, 3, 1313-1318.
20. 11. We as well as Albeck et al. (Albeck, A.; Fluss, S.; Persky, R. J. Am. Chem. Soc. 1996, 118, 3591-3596.) observed that peptidyl epoxides (Cbz-Gly-Leu-Ala-epoxide, Cbz-Gly-Leu-Phe-epoxide, Cbz-Ala-Ala-Phe-epoxide, and Cbz-Ala-Ala-Ala-epoxide) fail to inactivate α-chymotrypsin irrespective of stereochemistry at the α-position even under saturation conditions.
21. 12. (a) Henderson, R. J. Mol. Biol. 1970, 54, 341-354.
22. (b) Brady, K.; Wei, A.; Ringe, D.; Abeles, R. H. Biochemistry 1990, 29, 7600-7607.